Mupirocin enhances the biofilm formation of Staphylococcus epidermidis in an atlE-dependent manner

Int J Antimicrob Agents. 2023 Oct;62(4):106904. doi: 10.1016/j.ijantimicag.2023.106904. Epub 2023 Jun 28.

Abstract

The pathogenicity of Staphylococcus epidermidis is largely attributed to its exceptional ability to form biofilms. Here, we report that mupirocin, an antimicrobial agent widely used for staphylococcal decolonization and anti-infection, strongly stimulates the biofilm formation of S. epidermidis. Although the polysaccharide intercellular adhesin (PIA) production was unaffected, mupirocin significantly facilitated extracellular DNA (eDNA) release by accelerating autolysis, thereby positively triggering cell surface attachment and intercellular agglomeration during biofilm development. Mechanistically, mupirocin regulated the expression of genes encoding for the autolysin AtlE as well as the programmed cell death system CidA-LrgAB. Critically, through gene knockout, we found out that deletion of atlE, but not cidA or lrgA, abolished the enhancement of biofilm formation and eDNA release in response to mupirocin treatment, indicating that atlE is required for this effect. In Triton X-100 induced autolysis assay, mupirocin treated atlE mutant displayed a slower autolysis rate compared with the wild-type strain and complementary strain. Therefore, we concluded that subinhibitory concentrations of mupirocin enhance the biofilm formation of S. epidermidis in an atlE dependent manner. This induction effect could conceivably be responsible for some of the more unfavourable outcomes of infectious diseases.

Keywords: Biofilm; Mupirocin; Staphylococcus epidermidis; atlE; eDNA.

MeSH terms

  • Bacterial Proteins / genetics
  • Bacterial Proteins / metabolism
  • Biofilms
  • Mupirocin* / pharmacology
  • Staphylococcus / metabolism
  • Staphylococcus epidermidis* / genetics
  • Virulence

Substances

  • Mupirocin
  • Bacterial Proteins